$10.20B Market Cap.
PCVX Market Cap. (MRY)
PCVX Shares Outstanding (MRY)
PCVX Assets (MRY)
Total Assets
$3.51B
Total Liabilities
$205.50M
Total Investments
$2.75B
PCVX Income (MRY)
Revenue
$0
Net Income
-$463.93M
Operating Expense
$569.55M
PCVX Cash Flow (MRY)
CF Operations
-$452.63M
CF Investing
-$2.01B
CF Financing
$2.45B
PCVX Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | 0% | - | 0% | - |
PCVX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $3,511,318,000 (149.40%) | $1,407,917,000 (39.93%) | $1,006,178,000 (210.23%) | $324,337,000 (-17.43%) |
Assets Current | $1,787,985,000 (63.14%) | $1,095,954,000 (16.27%) | $942,555,000 (267.69%) | $256,348,000 (-34.10%) |
Assets Non-Current | $1,723,333,000 (452.42%) | $311,963,000 (390.33%) | $63,623,000 (-6.42%) | $67,989,000 (1678.89%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $3,305,819,000 (166.50%) | $1,240,468,000 (30.08%) | $953,613,000 (235.76%) | $284,018,000 (-17.88%) |
Property Plant & Equipment Net | $270,147,000 (144.21%) | $110,623,000 (249.54%) | $31,648,000 (-11.87%) | $35,912,000 (997.56%) |
Cash & Equivalents | $387,878,000 (-2.41%) | $397,451,000 (-52.38%) | $834,657,000 (1109.91%) | $68,985,000 (-82.14%) |
Accumulated Other Comprehensive Income | -$3,873,000 (-2263.69%) | $179,000 (149.58%) | -$361,000 (-49.79%) | -$241,000 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $2,748,157,000 (224.63%) | $846,554,000 (581.94%) | $124,139,000 (-39.44%) | $204,973,000 (0%) |
Investments Current | $1,359,330,000 (99.09%) | $682,776,000 (605.94%) | $96,719,000 (-45.35%) | $176,985,000 (0%) |
Investments Non-Current | $1,388,827,000 (747.99%) | $163,778,000 (497.29%) | $27,420,000 (-2.03%) | $27,988,000 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $48,452,000 (232.16%) | $14,587,000 (48.92%) | $9,795,000 (44.94%) | $6,758,000 (-77.31%) |
Accumulated Retained Earnings (Deficit) | -$1,388,319,000 (-50.19%) | -$924,392,000 (-77.04%) | -$522,126,000 (-74.83%) | -$298,641,000 (-50.40%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $71,110,000 (143.33%) | $29,224,000 (62.89%) | $17,941,000 (6.90%) | $16,783,000 (0%) |
Debt Current | $5,891,000 (-17.18%) | $7,113,000 (20.36%) | $5,910,000 (12.02%) | $5,276,000 (0%) |
Debt Non-Current | $65,219,000 (194.96%) | $22,111,000 (83.78%) | $12,031,000 (4.55%) | $11,507,000 (0%) |
Total Liabilities | $205,499,000 (22.72%) | $167,449,000 (218.56%) | $52,565,000 (30.37%) | $40,319,000 (-14.18%) |
Liabilities Current | $140,180,000 (-3.55%) | $145,338,000 (258.64%) | $40,525,000 (41.12%) | $28,716,000 (-38.72%) |
Liabilities Non-Current | $65,319,000 (195.41%) | $22,111,000 (83.65%) | $12,040,000 (3.77%) | $11,603,000 (9410.66%) |
PCVX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $92,902,000 (53.05%) | $60,700,000 (52.47%) | $39,810,000 (57.61%) | $25,259,000 (57.70%) |
Research & Development Expense | $476,644,000 (43.42%) | $332,341,000 (96.13%) | $169,451,000 (116.11%) | $78,411,000 (6.59%) |
Operating Expenses | $569,546,000 (21.69%) | $468,041,000 (101.52%) | $232,256,000 (124.03%) | $103,670,000 (15.73%) |
Interest Expense | $0 (0%) | $0 (0%) | $2,000 (-71.43%) | $7,000 (0.00%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$463,927,000 (-15.33%) | -$402,266,000 (-80.00%) | -$223,485,000 (-123.31%) | -$100,077,000 (-12.17%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$463,927,000 (-15.33%) | -$402,266,000 (-80.00%) | -$223,485,000 (-123.31%) | -$100,077,000 (-12.17%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$463,927,000 (-15.33%) | -$402,266,000 (-80.00%) | -$223,485,000 (-123.31%) | -$100,077,000 (-12.17%) |
Weighted Average Shares | $121,997,348 (25.57%) | $97,157,690 (49.75%) | $64,877,988 (24.95%) | $51,922,108 (75.73%) |
Weighted Average Shares Diluted | $121,997,348 (25.57%) | $97,157,690 (49.75%) | $64,877,988 (24.95%) | $51,922,108 (75.73%) |
Earning Before Interest & Taxes (EBIT) | -$463,927,000 (-15.33%) | -$402,266,000 (-80.00%) | -$223,483,000 (-123.33%) | -$100,070,000 (-12.17%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$569,546,000 (-21.69%) | -$468,041,000 (-101.52%) | -$232,256,000 (-124.03%) | -$103,670,000 (-15.73%) |
PCVX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$2,005,666,000 (-159.36%) | -$773,311,000 (-1136.82%) | $74,585,000 (135.13%) | -$212,308,000 (-19113.39%) |
Net Cash Flow from Financing | $2,448,508,000 (282.69%) | $639,813,000 (-25.74%) | $861,547,000 (4741.24%) | $17,796,000 (-95.25%) |
Net Cash Flow from Operations | -$452,627,000 (-52.51%) | -$296,790,000 (-73.97%) | -$170,597,000 (-40.53%) | -$121,393,000 (-160.34%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$9,359,000 (97.86%) | -$436,974,000 (-157.07%) | $765,672,000 (342.04%) | -$316,344,000 (-196.68%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$1,886,507,000 (-167.43%) | -$705,434,000 (-977.12%) | $80,426,000 (139.08%) | -$205,779,000 (0%) |
Capital Expenditure | -$119,159,000 (-75.55%) | -$67,877,000 (-1062.08%) | -$5,841,000 (10.54%) | -$6,529,000 (-490.86%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $2,462,800,000 (284.92%) | $639,813,000 (-25.74%) | $861,547,000 (4741.24%) | $17,796,000 (-93.29%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $426,000 (106.37%) | -$6,686,000 (-4980.29%) | $137,000 (131.21%) | -$439,000 (-604.60%) |
Share Based Compensation | $84,822,000 (73.96%) | $48,760,000 (106.17%) | $23,650,000 (120.43%) | $10,729,000 (97.44%) |
Depreciation Amortization & Accretion | $15,845,000 (55.79%) | $10,171,000 (10.60%) | $9,196,000 (166.01%) | $3,457,000 (146.05%) |
PCVX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -17.40% (45.63%) | -32.00% (26.94%) | -43.80% (-35.19%) | -32.40% (12.90%) |
Return on Average Assets (ROAA) | -16.50% (44.44%) | -29.70% (25.75%) | -40.00% (-41.84%) | -28.20% (-8.88%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -22.10% (54.81%) | -48.90% (65.90%) | -143.40% (-163.60%) | -54.40% (-117.77%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -21.54 (-42.01%) | -15.17 (-8.82%) | -13.94 (-13.09%) | -12.33 (-40.10%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 3.09 (-35.94%) | 4.82 (21.30%) | 3.97 (-10.18%) | 4.42 (12.95%) |
Debt to Equity Ratio (D/E) | 0.06 (-54.07%) | 0.14 (145.45%) | 0.06 (-61.27%) | 0.14 (4.41%) |
Earnings Per Share (EPS) | -3.8 (8.21%) | -4.14 (-20.35%) | -3.44 (-78.24%) | -1.93 (36.09%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -4.69 (-24.89%) | -3.75 (-37.98%) | -2.72 (-10.39%) | -2.46 (-52.48%) |
Book Value Per Share (BVPS) | 27.1 (112.23%) | 12.77 (-13.14%) | 14.7 (168.72%) | 5.47 (-53.27%) |
Tangible Assets Book Value Per Share (TABVPS) | 28.78 (98.62%) | 14.49 (-6.56%) | 15.51 (148.26%) | 6.25 (-53.01%) |
Enterprise Value Over EBIT (EV/EBIT) | -20 (-42.86%) | -14 (12.50%) | -16 (-45.45%) | -11 (0.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -20.49 (-47.55%) | -13.88 (15.67%) | -16.47 (-38.95%) | -11.85 (-8.76%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 12.76 (69.14%) | 7.54 (-67.58%) | 23.26 (160.55%) | 8.93 (7.54%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$571,786,000 (-56.80%) | -$364,667,000 (-106.68%) | -$176,438,000 (-37.93%) | -$127,922,000 (-167.99%) |
Enterprise Value (EV) | $9,180,517,656 (68.62%) | $5,444,340,485 (54.30%) | $3,528,481,398 (208.20%) | $1,144,880,385 (19.67%) |
Earnings Before Tax (EBT) | -$463,927,000 (-15.33%) | -$402,266,000 (-80.00%) | -$223,485,000 (-123.31%) | -$100,077,000 (-12.17%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$448,082,000 (-14.28%) | -$392,095,000 (-82.98%) | -$214,287,000 (-121.80%) | -$96,613,000 (-10.03%) |
Invested Capital | $3,054,370,000 (241.52%) | $894,352,000 (500.49%) | $148,937,000 (-38.81%) | $243,419,000 (704.99%) |
Working Capital | $1,647,805,000 (73.34%) | $950,616,000 (5.39%) | $902,030,000 (296.27%) | $227,632,000 (-33.47%) |
Tangible Asset Value | $3,511,318,000 (149.40%) | $1,407,917,000 (39.93%) | $1,006,178,000 (210.23%) | $324,337,000 (-17.43%) |
Market Capitalization | $10,202,747,656 (70.74%) | $5,975,665,485 (57.79%) | $3,787,100,398 (201.58%) | $1,255,758,385 (-7.24%) |
Average Equity | $2,673,392,000 (112.96%) | $1,255,332,750 (146.27%) | $509,741,750 (65.24%) | $308,484,000 (28.51%) |
Average Assets | $2,812,409,000 (107.75%) | $1,353,739,000 (142.54%) | $558,144,750 (57.36%) | $354,702,500 (3.15%) |
Invested Capital Average | $2,099,884,000 (155.16%) | $822,963,500 (428.05%) | $155,848,500 (-15.30%) | $183,990,250 (731.45%) |
Shares | 124,636,546 (30.98%) | 95,153,909 (20.48%) | 78,980,196 (49.63%) | 52,785,136 (3.60%) |
